# Clinical Trial to Evaluate the Efficacy and Safety of 'DW1601' in Acute Bronchitis

> **NCT04260555** · PHASE3 · UNKNOWN · sponsor: **Daewon Pharmaceutical Co., Ltd.** · enrollment: 204 (estimated)

## Conditions studied

- Acute Bronchitis

## Interventions

- **DRUG:** DW1601
- **DRUG:** DW16011
- **DRUG:** DW16012

## Key facts

- **NCT ID:** NCT04260555
- **Lead sponsor:** Daewon Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-20
- **Primary completion:** 2019-12-09
- **Final completion:** 2021-02-28
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2020-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04260555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04260555, "Clinical Trial to Evaluate the Efficacy and Safety of 'DW1601' in Acute Bronchitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04260555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*